Scarica l'app Stockscreener
7.495
0.74%
0.055
Dopo l'orario di chiusura:
7.46
-0.035
-0.47%
Precedente Chiudi:
$7.44
Aprire:
$7.5
Volume 24 ore:
192.52K
Relative Volume:
0.77
Capitalizzazione di mercato:
$276.02M
Reddito:
$128.45M
Utile/perdita netta:
$6.54M
Rapporto P/E:
-2.2575
EPS:
-3.32
Flusso di cassa netto:
$-8.79M
1 W Prestazione:
+0.20%
1M Prestazione:
+36.40%
6M Prestazione:
+33.36%
1 anno Prestazione:
+2.95%
Intervallo 1D:
$7.46
$7.74
Intervallo di 1 settimana:
$6.83
$7.99
Portata 52W:
$3.6793
$8.90
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Nome
Lifecore Biomedical Inc
Settore
Telefono
(952) 368-4300
Indirizzo
3515 LYMAN BOULEVARD, CHASKA
Confronta LFCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.495 | 276.02M | 128.45M | 6.54M | -8.79M | -3.32 |
|
ZTS
Zoetis Inc
|
176.74 | 79.74B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 43.95B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 43.02B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.78B | 15.05B | -883.30M | 1.89B | 1.53 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-05 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
Lifecore extends credit terms, simplifies interest rates By Investing.com - Investing.com Canada
Lifecore extends credit terms, simplifies interest rates - Investing.com India
Lifecore Biomedical Strengthens Financial Position with Key Moves - TipRanks
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO - GlobeNewswire
Lifecore Biomedical Extends Credit Facility to 2027, Secures $24.3M Financing | LFCR Stock News - StockTitan
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Soars 36% But It's A Story Of Risk Vs Reward - Simply Wall St
Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $10.00 - Defense World
Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $10.00 at Craig Hallum - MarketBeat
Lifecore Biomedical shares target upgraded, keeps buy on growth prospects By Investing.com - Investing.com UK
Earnings call: Lifecore Biomedical Q1 fiscal 2025 shows steady growth - Investing.com
Lifecore Biomedical Hosts Virtual Investor Day - The Manila Times
Earnings call: Lifecore Biomedical Q1 Fiscal 2025 highlights growth strategy - Investing.com
Earnings call: Lifecore Biomedical Q1 Fiscal 2025 highlights growth strategy By Investing.com - Investing.com Canada
Lifecore Biomedical Plans Strategic Growth and Transformation - TipRanks
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus.com
Trend Tracker for (LFCR) - Stock Traders Daily
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR) - Insider Monkey
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) biggest owners are individual investors who got richer after stock soared 14% last week - Simply Wall St
Lifecore Biomedical to Present at Stephens Annual Investment Conference - The Manila Times
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge funds - Yahoo Finance
Lifecore Biomedical: Finally A 'Pure Play' CDMO Business - Seeking Alpha
Lifecore to host virtual investor day on November 21 - Nasdaq
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024 - The Manila Times
Lifecore Biomedical (LFCR) to Host Virtual Investor Day: Growth Strategy Unveiling | LFCR Stock News - StockTitan
Lifecore Biomedical (NASDAQ:LFCR) Trading Up 4.5%Time to Buy? - MarketBeat
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations - GlobeNewswire
Lifecore Biomedical Makes Leadership Appointments - Contract Pharma
Chaska’s Lifecore looks to growth in coming years after emerging from delisting challenge - Star Tribune
How To Trade (LFCR) - Stock Traders Daily
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer - Benzinga
Hyaluronic Acid (HA) Raw Material Market Size And Forecast -Salix Pharmaceuticals, ALLERGAN, Lifecore Biomedical, LLC, S – IndiaPolitics.com - IndiaPolitics.com
Johnson Fistel LLP Investigates Lifecore Biomedical, Inc’s - GlobeNewswire
Q3 2025 Earnings Forecast for Lifecore Biomedical, Inc. Issued By Barrington Research (NASDAQ:LFCR) - MarketBeat
Brokers Set Expectations for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR) - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock By Investing.com - Investing.com South Africa
Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc - GuruFocus.com
Wynnefield Partners Small Cap Acquires 122,930 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock - Investing.com
Lifecore Biomedical stock price target increased on growth prospects By Investing.com - Investing.com UK
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results By Investing.com - Investing.com Australia
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results - Investing.com India
Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ... By GuruFocus - Investing.com Canada
Q1 2025 Lifecore Biomedical Inc Earnings Call Transcript - Stockxpo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Marshall Wace LLP - MarketBeat
exhibit991-lfcrq1fy25ear.htm - SEC.gov
Lifecore Biomedical: Fiscal Q1 Earnings Snapshot - mySA
Lifecore Biomedical completes $24.3M private stock sale - Investing.com
Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):